Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
36%
OVERLAP
BY WEIGHT
29
# OF OVERLAPPING
HOLDINGS
WDNA
90
HOLDINGS
35%
ALSO IN HELX
HELX
75
HOLDINGS
43%
ALSO IN WDNA
SECTOR DRIFT (WDNA minus HELX)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in HELX |
Overlap | |
|---|---|---|---|---|
| NATERA INC | 4.4% | 6.2% | 4.4% | |
| ALNYLAM PHARMACEUTICALS INC | 3.0% | 3.6% | 3.0% | |
| BRIDGEBIO PHARMA, INC. | 4.0% | 2.4% | 2.4% | |
| ELI LILLY & CO | 2.3% | 2.9% | 2.3% | |
| UNITED THERAPEUTICS CORP | 2.2% | 3.5% | 2.2% | |
WDNA Overweight Relative to HELX
| BLUEPRINT MEDICINES CORP. | 3.8% | |
| NOVOZYMES A/S-B SHARES | 3.2% | |
| STOKE THERAPEUTICS, INC. | 2.3% | |
| AGIOS PHARMACEUTICALS INC | 2.1% | |
| NOVARTIS AG | 1.9% | |
| GILEAD SCIENCES INC | 1.9% | |
| VERICEL CORPORATION | 1.8% | |
| BRIDGEBIO PHARMA, INC. | 1.6% | |
| JOHNSON & JOHNSON | 1.5% | |
| DUPONT DE NEMOURS INC | 1.5% |
WDNA Underweight Relative to HELX
| MEDPACE HOLDINGS, INC. | -5.3% | |
| INSMED INC | -4.6% | |
| KRYSTAL BIOTECH, INC. | -4.0% | |
| SAMSUNG BIOLOGICS CO., LTD. | -3.6% | |
| GUARDANT HEALTH, INC. | -2.7% | |
| CADENCE DESIGN SYS INC | -2.5% | |
| VERTEX PHARMACEUTICALS INC | -2.4% | |
| LIGAND PHARMACEUTICALS-CL B | -2.3% | |
| REGENERON PHARMACEUTICALS | -2.3% | |
| SARTORIUS AG PREF | -2.1% |